Corporate

CLINUVEL
Posted by CLINUVEL
January 27, 2023

Technical Note: Developing a melanocortin pipeline

CLINUVEL today announced an update on its commercial development of the analogue...

Read More
CLINUVEL
Posted by CLINUVEL
January 23, 2023

NEURACTHEL® manufacturing processes advance

CLINUVEL today announced an update on its commercial development of the analogue...

Read More
CLINUVEL
Posted by CLINUVEL
January 12, 2023

News Kommuniqué 1

Happy New Year to all our stakeholders for 2023, a year in...

Read More
CLINUVEL
Posted by CLINUVEL
January 10, 2023

News Communiqué I

On behalf of the CLINUVEL team and Board, I wish all readers...

Read More
CLINUVEL
Posted by CLINUVEL
December 23, 2022

CLINUVEL Communiqué VI

Melbourne, Australia, 23 December 2022 ASX: XETRA-DAX: Level 1 ADR: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
November 17, 2022

Jefferies London Healthcare Conference

CLINUVEL's Chief Executive Officer, Dr Philippe Wolgen, presents to the Jefferies Healthcare...

Read More
CLINUVEL
Posted by CLINUVEL
November 9, 2022

CLINUVEL Communiqué V

News Communiqué V discusses CLINUVEL's strong financial results in the face of...

Read More
CLINUVEL
Posted by CLINUVEL
October 26, 2022

Chair's Address

Dear Shareholders, I have a few key points to make before we...

Read More
CLINUVEL
Posted by CLINUVEL
October 26, 2022

Results of Annual General Meeting 2022

In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations...

Read More
CLINUVEL
Posted by CLINUVEL
October 21, 2022

CLINUVEL Pharmaceuticals Investor Briefing Melbourne

CLINUVEL held an Investor Briefing in Melbourne, with a presentation by Managing...

Read More
CLINUVEL
Posted by CLINUVEL
October 14, 2022

CLINUVEL's Sydney Soirée 2022

CLINUVEL's Sydney Soirée 2022 presentation

Read More
CLINUVEL
Posted by CLINUVEL
September 23, 2022
CLINUVEL
Posted by CLINUVEL
September 19, 2022

Strategic Update V

CLINUVEL today announced its fifth Strategic Update, focused on the evolution and...

Read More
CLINUVEL
Posted by CLINUVEL
September 13, 2022

H.C. Wainwright 24th Annual Global Investment Conference

CLINUVEL's Head of Investor Relations, Malcolm Bull, presents to the H.C. Wainwright...

Read More
CLINUVEL
Posted by CLINUVEL
September 2, 2022

CLINUVEL Kommuniqué IV

Seit dem letzten News Communiqué vom 23. Juni hat CLINUVEL die Entwicklung...

Read More